Clinical manifestations, antimicrobial therapy, and prognostic factors of monomicrobial Acinetobacter baumannii complex bacteremia - 08/08/11
Corresponding author. Department of Internal Medicine, National Cheng Kung University Hospital, #138, Sheng Li Road, Tainan, 704, Taiwan. Tel.: +886 6 235 3535x3596; fax: +886 6 275 2038.Summary |
Objectives |
Bacteremia due to Acinetobacter baumannii complex (ABC), which composed of four genomic species (gen. sp.), is a serious and potentially fatal condition. The epidemiology and outcome of such infections due to individual gen. sp. remain undefined.
Methods |
A retrospective study of patients with monomicrobial ABC bacteremia over six years was conducted at a medical center to determine the association of gen. sp. with clinical outcome.
Results |
Included were 291 patients with monomicrobial ABC bacteremia. Of them, 222 (76.3%) patients had bacteremia caused by gen. sp. 2, i.e. A. baumannii. The presence of multidrug-resistant phenotype was the only independent predictor of Acinetobacter gen. sp. 2 bacteremia (adjusted odd ratio, 7.5; 95% confidence interval, 3.8–14.7; P < 0.001). Patients with Acinetobacter gen. sp. 2 bacteremia had a higher sepsis-related (P = 0.006) and 30 day (P = 0.028) mortality rates than the non-Acinetobacter gen. sp. 2 group. The fatal outcome was independently associated with high SPAS II scores (P = 0.002), rapidly fatal underlying diseases (P = 0.002), bacteremia caused by Acinetobacter gen. sp. 2 (P = 0.01), inappropriate definitive antimicrobial therapy (P < 0.001), and severe sepsis (P < 0.001).
Conclusion |
Acinetobacter gen. sp. 2 bacteremia heralded a worse clinical outcome, and therefore the gen. sp. identification of ABC bacteremic isolates is justified.
Le texte complet de cet article est disponible en PDF.Keywords : Species identification, Bacteremia, Acinetobacter baumannii, Prognostic factor, Antimicrobial therapy
Plan
 | This study was presented in part at the Annual Meeting of the Infectious Disease Society of Taiwan, Taipei, Taiwan, January 12–13, 2008. |
Vol 61 - N° 3
P. 219-227 - septembre 2010 Retour au numéro
Article précédent
- Impact of inappropriate antimicrobial therapy on outcome in patients with hospital-acquired pneumonia caused by Acinetobacter baumannii
- Mi Kyong Joung, Ki Tae Kwon, Cheol-In Kang, Hae Suk Cheong, Ji-young Rhee, Dong Sik Jung, Seung Min Chung, Jeong A. Lee, Soo-youn Moon, Kwan Soo Ko, Doo Ryeon Chung, Nam Yong Lee, Jae-Hoon Song, Kyong Ran Peck
- Diagnostic usefulness of a T-cell-based assay for osteoarticular tuberculosis
- Oh-Hyun Cho, Su-Jin Park, Ki-Ho Park, Yong Pil Chong, Heungsup Sung, Mi-Na Kim, Sang-Oh Lee, Sang-Ho Choi, Jun Hee Woo, Yang Soo Kim, Sung-Han Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?